Workflow
AYON
icon
Search documents
Apyx Medical outlines $50.5M–$52.5M 2025 revenue target, signals AYON launch momentum (NASDAQ:APYX)
Seeking Alpha· 2025-11-06 19:36
Core Insights - The article discusses the importance of enabling Javascript and cookies in browsers to ensure proper functionality and access to content [1] Group 1 - The article emphasizes that users may be blocked from proceeding if an ad-blocker is enabled [1]
Apyx Medical Corporation (APYX) Virtual KOL Event
Seeking Alpha· 2025-10-15 00:10
Core Viewpoint - Apyx Medical positions itself as a leader in the surgical aesthetics market, emphasizing the unique benefits of surgical aesthetics in providing durable and transformational results [4]. Group 1: Company Overview - Apyx Medical is hosting a virtual KOL event to discuss the commercial launch of its product AYON [3]. - The event features Dr. Vanek, who will share his experiences with AYON, indicating the company's focus on expert insights [2]. Group 2: Product Launch - The majority of the event will be dedicated to discussing the commercial launch of AYON, highlighting its significance in the company's strategy [3].
Apyx Medical Corporation - Special Call
Seeking Alpha· 2025-10-14 22:56
Group 1 - Apyx Medical is positioning itself as a leader in the surgical aesthetics market, emphasizing that surgical aesthetics provide durable and transformational results for patients [4] - The company is launching a new product, AYON, which will be a focal point of the event [3] - The market dynamics have been notably influenced by the introduction of GLP-1 drugs for weight loss, which has changed the landscape of surgical aesthetics [4] Group 2 - The event features Dr. Vanek as a key opinion leader (KOL), who will share his experiences with the AYON product [2][3] - The agenda includes an introduction by the CEO, a discussion on the commercial launch of AYON, and a Q&A session at the end [3]